Posts filtered by tags: San Francisco blog main[x]


 

CI Security Raises $9.6M to Help Customers Manage Cyber Threats

CI Security, a startup that provides its customers with cybersecurity software and expertise in detecting and responding to digital intrusions and threats, announced Monday it has raised $9.6 million in new funding. Seattle-based CI Security, which was previously known as Critical Informatics, says it plans to use some of the new cash to continue developing its products and services.The only investor CI Security named in a news release announcing the Series B round was East Seattle Partners, wh...
Tags: Amazon, Deals, Startups, Internet Of Things, Microsoft, Government, Trends, Tech, Cybersecurity, Data Breach, Vc, Hacking, Hacks, Healthcare, Aws, Manufacturing


SPECIAL REPORT: 2019 Blockchain Outlook — Reality Check

After a breakout year in 2017, the blockchain sector suffered a series of blows in 2018, from crashing cryptocurrency prices to increased regulatory scrutiny of crypto ventures and deepening skepticism about whether the technology was actually useful. Now, the industry has entered a crucial phase where blockchain developers need to overcome the limitations of the technology and find use cases that will win widespread adoption by businesses and organizations.In this Xconomy Special Report, our v...
Tags: Startups, Microsoft, Azure, Trends, Tech, Vc, Gartner, Ibm, National, Tim Draper, Special Report, Blockchain, Menlo Ventures, Draper Associates, Filament, David Richards


Join Xconomy for Our 8th Annual Napa Summit, June 13-14

Google. Amazon. Genentech. Those are some of the companies you’ll hear from at this year’s Napa Summit, the Xconomy Retreat on Technology, Jobs, and Growth.This is our most special event of the year—the eighth year we’ve held it—and it’s limited to about 100 VIP guests. We’ll tackle big trends, challenges, and opportunities in areas like venture capital, software, genomics, digital medicine, education, and diversity. The program is interdisciplinary and highly interactive.It all takes place ove...
Tags: Google, Amazon, Startups, Technology, Events, Trends, Diversity, It, People, Vc, Software, Culture, Innovation, Venture Capital, Genomics, National


Aptiv Expands Driverless Car Testing, Opens Chinese Mobility Center

Aptiv, a global automotive technology company, announced last week that it has opened a new innovation hub in China—the fastest growing front in the self-driving tech wars.The new entity is called the China Autonomous Mobility Center, and as a result of the move, Shanghai joins Aptiv’s roster of driverless car testing locations, which also include Singapore, Boston, Pittsburgh, and Las Vegas. The company said the Shanghai center will concentrate on the development and application of its level 4...
Tags: Startups, Hardware, Entrepreneurship, China, Trends, Software, Innovation, Shanghai, Mobility, Las Vegas, Detroit, Delphi Automotive, National blog main, Boston blog main, National top stories, San Francisco blog main


Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More

Persistence and perseverance were the themes of two of our top stories this week.First there’s the story of Nationwide Children’s Hospital. The Columbus, Ohio, hospital chose to invest in gene therapy when the field was in its darkest days. After some ups and downs, the team it put in place helped advance some of the most promising gene therapies currently in human testing—and put Nationwide in the national spotlight as one of those treatments nears FDA approval.Then there’s Suzanne Ildstad. A ...
Tags: Deals, Startups, Usa, Trends, Vc, Fda, National, University of Pennsylvania, Novartis, Allergan, Biotech, Crispr, Life Sciences, Clinical Trials, Amgen, Gilead Sciences


Hookipa’s IPO Raises $84M for Drugs to Reprogram the Immune System

Hookipa Pharma has raised $84 million in an initial public offering that will fund development of experimental treatments developed to reprogram the immune system to treat infectious diseases and cancer.But Hookipa (NASDAQ: HOOK) had to downsize its IPO, offering only 6 million shares at $14 apiece. That was the low end of its targeted $14 to $16 range. Hookipa had initially planned to sell 6.7 million shares. In the first day of trading Thursday, Hookipa shares hovered around the IPO price.Hoo...
Tags: Deals, New York, Ipo, Hiv, Trends, Investing, Prostate Cancer, Immunotherapy, Biotech, Life Sciences, Clinical Trials, Gilead Sciences, National blog main, San Francisco blog main, Hookipa, Cancer Immunotherapy


Redox Wrangles $33M to Become Healthcare’s Go-To Data Integrator

As hospitals and clinics have shifted from paper-based records to digital systems, one of the biggest challenges has been sharing patient data between healthcare providers, and between providers and outside software applications. This “interoperability” problem has created a market for companies such as Redox, a Madison, WI-based startup that develops software tools to make the flow of patient information more seamless.Redox has worked on the problem for about five years, and now investors thin...
Tags: Startups, Microsoft, Trends, Tech, Vc, Software, Healthcare, Wisconsin, Health Records, Fitbit, Api, RRE Ventures, Battery Ventures, Healthtech, Phoenix, Cleveland Clinic


$100M For Talaris Gives Surgeon a Shot to Reinvent Organ Transplants

When Novartis dissolved its gene and cell therapy unit a few years ago, a bunch of projects the Swiss pharma giant had incubated were tossed aside. One of them was the work of surgeon Suzanne Ildstad, who has spent decades trying to develop a new way to improve the health outcomes of patients who need organ transplants.That work has just been salvaged. If it plays out as Ildstad hopes, her company might not only help transform treatment for kidney failure patients—but possibly, for people suffe...
Tags: Deals, Startups, Boston, Trends, Vc, National Institutes of Health, Novartis, Stem Cell, Stanford University, Life Sciences, Blackstone Group, Louisville Ky, National blog main, New York blog main, New York top stories, Seattle blog main


6sense Raises $27M to Uncover Hidden Interests of B2B Buyers

Let’s say you’re wondering whether another software provider could do a better job for your business than the one you already use. You start a web search on its competitors. Suddenly, you get a friendly message from your current software provider, asking how things are going.Was it a sixth sense? Nope, as you can probably guess by now. It’s technology.Companies such as 6sense are using advanced data analytics and artificial intelligence software to help their customers find early signals of int...
Tags: Deals, Startups, Mobile, Internet, Entrepreneurship, Funding, San Francisco, Trends, Tech, Cisco, Web, It, Vc, Artificial Intelligence, Software, Fundraising


Metamoto’s Jeff Blackburn on AV Testing and Why Waymo Leads the Pack

In the development of self-driving cars, once a vehicle is ready for the validation stage, it’s not always practical or affordable to test them on open roads. Given the hundreds of different scenarios developers want autonomous vehicles to experience and react to—weather, traffic conditions, pedestrian activity, land markings, and more—simulation offers an alternative to on-road testing.At the M:Bility conference held in Dearborn a few weeks ago, Xconomy had an opportunity to chat with Metamoto...
Tags: Startups, Entrepreneurship, Trends, Tech, Software, Innovation, Automotive Industry, Detroit, Blackburn, Alphabet, University Of Michigan, Virginia Tech, Dearborn, Bility, Jeff Blackburn, National blog main


Lyft, Uber, and the Changing Disclosure Rules For Unicorn IPOs

When a much-watched tech company such as Lyft, Uber, or Pinterest files for an initial public stock offering, people eagerly scour the sudden trove of information that such a private business must finally disclose when it begins to offer shares to the general public, rather than only to sophisticated inside investors such as venture capital firms.For newly public company Lyft, (NASDAQ: LYFT) though, the IPO disclosure requirements were significantly lower than they would usually be for business...
Tags: Deals, Startups, Transportation, Mobile, Lyft, Uber, Hardware, Pinterest, Internet, Entrepreneurship, Ipo, Funding, San Francisco, Trends, Tech, Financial Crisis


Thwarting Opposition, Bristol Gets Shareholder OK for $74B Celgene Buyout

The early opposition has turned out to be just noise. Shareholders of Bristol-Myers Squibb today approved the pharma giant’s planned buyout of Celgene, paving the way for a deal that will create one of the largest biopharma organizations in the world, and send ripples throughout the sector. (NYSE: BMY) said Friday that more than 75 percent of its shareholders voted to approve the deal at a meeting on Friday. Some 98 percent (NASDAQ: CELG) of Celgene’s stockholders supported the deal, the compa...
Tags: Deals, New York, Trends, Merck, M&a, Life Sciences, Nyse, Celgene, Bristol-myers Squibb, National blog main, New York blog main, New York top stories, Seattle blog main, Seattle top stories, Boston blog main, National top stories


AskBio Reels In $235M to Advance Gene Therapy Clinical Trials

Asklepios BioPharmaceutical (AskBio) has raised $235 million in financing to support its research and development of gene therapies for rare, genetic disorders.The funding came from TPG Capital and Vida Ventures, which together invested $225 million and gained a minority stake in the Research Triangle Park, NC, company. Concurrent with that investment, AskBio’s founders and board members invested $10 million. The AskBio funding is the latest in a flurry of gene therapy investments that have swe...
Tags: Deals, Drugs, Trends, Investing, Venture Capital, Fda, Pfizer, Parkinson's Disease, Biotech, Tpg Capital, Life Sciences, Clinical Trials, Roche, Thermo Fisher Scientific, Biogen, University of North Carolina at Chapel Hill


Active Capital Leads $1.8M Round for Back Office’s AI Bookkeeping

San Antonio—Active Capital is leading a $1.8 million seed funding round for West Palm Beach, FL-based automated bookkeeping software maker Back Office. 500 FinTech, PlugNPlay Ventures, and angel investors also participated, according to Active.Back Office says it uses artificial intelligence-driven software to automate revenue and expense reporting (among other accounting measures) for businesses. It has a team of in-house bookkeepers who help on-board customers’ data into the software, which c...
Tags: Startups, Accelerator, Florida, Texas, Technology, Trends, Startup, Tech, Investing, Investment, Vc, Artificial Intelligence, Software, Automation, Venture Capital, Ai


VC Trends in 2019: More Money, Fewer Deals But Women Still Get Less

If you’ve been following venture capital trends, what you expected to happen in the first quarter of 2019 did: More money is being invested in fewer deals, and women founders still are getting less of it than men.Venture firms sent $32.6 billion into startups nationally during the first three months of 2019, the second largest amount for any quarter since at least 2006, according to data released overnight by PitchBook and the National Venture Capital Association. But that large sum came from o...
Tags: Deals, Startups, Lyft, Uber, Hardware, Entrepreneurship, Softbank, Funding, Women, Trends, Tech, Vc, Software, Physics, Pwc, Venture Capital


Klaviyo Puts Google, Facebook, Amazon on Notice With $150M Raise

Klaviyo, a Boston e-commerce startup, wants retailers to take their advertising spending back from the tech behemoths Google, Amazon, and Facebook.The thinking behind the push, according to CEO Andrew Bialecki, is whether in the long term companies are better off handing over their ad dollars or doing the work and “owning” the marketing themselves.“How do we get off this drug that is advertising?” Bialecki says.To compete with the likes of Google (NASDAQ: GOOGL), Amazon (NASDAQ: AMZN), and Face...
Tags: Google, Amazon, Startups, Mobile, Facebook, Internet, Boston, Advertising, Trends, Tech, Website, It, Sms, Software, Email Marketing, Adtech


Global Detroit, U-M Team on Program to Boost Immigrant-Led Startups

The American Dream was once a fairly simple concept: The nation would welcome strivers from across the world and invite them to pull themselves up by their bootstraps, work hard, pay taxes, and become contributing citizens. However, immigration has become a highly charged political issue in the current era, making things more complicated.That’s one reason Global Detroit and the University of Michigan’s Economic Growth Institute have partnered on a program to help international student and immig...
Tags: Startups, Entrepreneurship, Immigration, Trends, Tech, Innovation, Brad Feld, Detroit, STEM education, International Students, Foundry Group, Duo Security, William Davidson Foundation, University of Massachusetts Boston, National blog main, Boston blog main


Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More

Scott Gottlieb’s last day as FDA commissioner is today. His resignation announcement last month surprised some, given the earlier denials about leaving. But after two years of commuting between Connecticut, where his family remained, and the FDA’s Maryland headquarters, he decided to step down from the agency.What will Gottlieb’s legacy be? His efforts to curb teen vaping comes to mind. Or maybe it’s regulation. While Gottlieb remained mindful of the FDA’s oversight role, he also tried to strea...
Tags: Deals, Startups, Maryland, Breast Cancer, Trends, Investing, Lung Cancer, Connecticut, Cigna, Venture Capital, Fda, National, Novartis, Pfizer, Biotech, Insulin


NGM Bio’s IPO Raises $107M as NASH Drug Continues Clinical Testing

So far this year, NGM Biopharmaceuticals has licensed a drug to Merck, extended a research agreement with that partner, and laid the groundwork to continue mid-stage testing of its wholly-owned lead compound. Now it can add a $107 million IPO to the list.Late Wednesday, NGM sold appoximately 6.7 million shares for $16 apiece, the high end of the price range the South San Francisco company had planned. Those shares are expected to begin trading on the Nasdaq exchange Thursday under the stock sym...
Tags: Deals, Drugs, Ipo, Cancer, San Francisco, Trends, Investing, Merck, Diabetes, Venture Capital, Fda, Type 2 Diabetes, Biotech, Nasdaq, Life Sciences, Clinical Trials


FarmWise and Roush Partner to Develop Robots that Weed Farm Fields

We’ve heard a lot about autonomous cars over the past few years, but there are other applications for self-driving technology, including agriculture.Silicon Valley startup FarmWise this week announced a new partnership with Livonia, MI-based Roush, a legacy manufacturer and engineering services firm, to develop and test an autonomous machine that weeds row crops. FarmWise co-founder and chief technology officer Thomas Palomares declined to disclose the monetary value of the partnership.FarmWise...
Tags: Startups, Roundup, Entrepreneurship, Trends, Tech, Farming, Innovation, Agriculture, Silicon Valley, Autonomous Machines, Detroit, Herbicides, Self-driving, Roush, Livonia, National blog main


Go Behind the Hacker Frontlines at Cyber Madness in Boston April 8

Criminal hackers might get most of the headlines, but there are plenty of “ethical” hackers helping companies and organizations spot and fix vulnerabilities in their cyber defenses.On April 8, you can go behind the scenes of the hacker frontlines at Xconomy’s “Cyber Madness: Case Studies in Security,” an afternoon conference in Boston focused on how companies have solved security problems. In one session, HackerOne CEO Marten Mickos and Mapbox information security engineer Olivia Brundage will ...
Tags: Startups, Boston, Trends, Tech, Cisco, Cybersecurity, Carbonite, Mapbox, HackerOne, Marten Mickos, Sam King, Raytheon, Veracode, Corey Thomas, Mohamad Ali, National blog main


Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More

A week after , the ripple effects are still being felt—and not just by Biogen, which lost billions of dollars in market value in a flash.We’ll kick off this week’s roundup with the aducanumab reaction, which includes plenty of thoughts about the future of the so-called “amyloid hypothesis” and what’s next for another Biogen Alzheimer’s drug that has had mixed results.We’ll also check in on the gene therapy deal spree, the big week in national healthcare policy, and the preparations several com...
Tags: Deals, Obamacare, Trends, Alzheimer's Disease, Affordable Care Act, National, Pfizer, Medicaid, Xarelto, Federal Trade Commission, Life Sciences, Bayer, Clinical Trials, Celgene, Gilead Sciences, Eisai


Lyft Raises $2.2B in IPO, Pegging Valuation at Over $24B

Investors eager to bet on the mobility industry’s future handed ride-hailing company Lyft $2.2 billion in new capital Thursday as the company completed an IPO that set its market capitalization at $24.3 billion, The New York Times reported.Lyft sold 30.8 million shares at $72 apiece, according to Renaissance Capital—the top of a new range that Lyft originally set at $62 to $68. The company was valued at $15.1 billion at the time of its last fundraising in mid-2018.Lyft’s pricey showing rivals A...
Tags: Deals, Startups, Mobile, Lyft, Uber, Hardware, Marketplace, Pinterest, Entertainment, Internet, Entrepreneurship, Funding, US, San Francisco, Trends, Tech


Bolt Founder Ben Einstein Leaves Hardware Tech VC Firm

Ben Einstein, co-founder and general partner of hardware-focused investor Bolt, says he has left the venture capital firm he started as his partner, Grace, enters chemotherapy for a cancer diagnosis.“Through this gut-wrenching experience, the things I enjoy doing and that give me energy are clearer than ever: I am a builder,” Einstein wrote in a post on Medium. “My life revolves around the process of creating new things; from hardware products and companies to relationships and community, my li...
Tags: Boston, Boston blog main, Boston top stories, National blog main, San Francisco blog main, San Francisco top stories, Ben Einstein, Bolt, Cancer, Chemotherapy, Desktop Metal, Hardware, Machine Metrics, RoboticsAI, San Francisco, Sense


CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M

The high-stakes race to use CRISPR gene editing technology to create medicines has been underway for years now, and human trials are just starting. But the idea of using CRISPR as a tool to detect and diagnose a disease has been gaining traction, too, and the launch of a new startup today called Sherlock Biosciences marks the latest step.Sherlock has been formed around technologies licensed from the Broad Institute of MIT and Harvard University, dubbed “SHERLOCK” and “INSPECTR,” respectively, t...
Tags: Deals, Startups, Boston, Trends, Vc, Harvard University, Sherlock, Crispr, Illumina, Life Sciences, Jim Collins, Broad Institute of MIT, Jennifer Doudna, Gene Editing, Feng Zhang, David Walt


New Funding for Workplace Software Firms Skedulo and Scope AR

Two young San Francisco companies on Wednesday announced fundraisings to bolster their online services aimed at improving workforce efficiency.—Skedulo, which helps managers schedule assignments for field service personnel, says it raised $28 million in a Series B funding round led by M12, Microsoft’s corporate venture arm. Joining in the round were previous investors Blackbird, a venture capital firm based near Sydney, Australia, and Palo Alto, CA-based Costanoa Ventures. M12 principal Priya S...
Tags: Deals, Startups, Mobile, Microsoft, Workplace, Internet, Entrepreneurship, Funding, San Francisco, Trends, Tech, Unilever, Web, It, Vc, Software


New Accelerator Aims For Social Change With AR, VR, Gaming Startups

Games for Change, a non-profit that promotes the use of games and immersive technology for social good, is taking applications from startup teams for a new accelerator program it’s launching in New York City.New York-based Games for Change already encourages game and XR developers, by a variety of means, to build societal benefits into their designs. The organization, founded in 2004, holds an annual festival with demos, workshops, and training sessions, and also operates awards programs and st...
Tags: Startups, Games, Internet, Entrepreneurship, Funding, San Francisco, Trends, Tech, Web, It, Vc, Software, Innovation, Venture Capital, Virtual Reality, Berkshire Hathaway


Why Comma.ai, Maker of Self-Driving Tech, is Moving to San Diego

Tech salaries may not be as high outside of Silicon Valley, but neither is the cost of operating a business—or the cost of living.San Diego’s startup community has rejoiced in recent months as massive companies that employ thousands of engineers—including Amazon (NASDAQ: AMZN), Apple (NASDAQ: AAPL), and the tech arm of Walmart (NYSE: WMT)—have announced expansions in the region.Local entrepreneurs hope that investment will make other tech businesses, including early-stage companies, more comfor...
Tags: Startups, Elon Musk, Hardware, Entrepreneurship, Trends, Tech, Tesla, Bloomberg, Palo Alto, Software, San Diego, Silicon Valley, Self-driving Cars, George Hotz, Aapl, Ashlee Vance


M:Bility Conference: Panel Talks Factors Fueling Future of AV Industry

At AutoWorld’s M:Bility conference in Dearborn, MI, this week, a wide variety of topics pertaining to the mobility industry and the development of driverless technology were covered in keynote and panel discussions, including mapping and sensors, artificial intelligence, automotive data, mobility-as-a-service, electrification, and 5G connectivity.However, running through all topics was a measure of caution as industry insiders worked to adjust expectations as to when fully autonomous (or nearly...
Tags: Startups, Uber, Entrepreneurship, Trends, Tech, Software, Electric Vehicles, Auto Industry, Innovation, Gm, Mobility, Detroit, Smart Cities, Boeing, Valeo, Bility


Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More

While all eyes in the biopharmaceutical world are currently trained on Bristol-Myers Squibb’s proposal to buy Celgene for $74 billion, it wasn’t that long ago that another company’s gaze was fixed on the Summit, NJ, drug maker.In the early 2000s, before the FDA approved Celgene’s flagship multiple myeloma drug lenalidomide (Revlimid), Novartis (NYSE: NVS considered buying the company. It passed, unwilling to risk billions on an unapproved drug. Those details came from biopharma dealmaker George...
Tags: Deals, Startups, China, Ipo, Cancer, Trends, Investing, Merck, Colorectal Cancer, Multiple Sclerosis, Harvard University, Health Insurance, Astrazeneca, Center For Medicare And Medicaid Services, Fda, National